arrow
返回

Lipoic acid in multiple sclerosis: a pilot study

delete2005-04-01
delete125
PRE
AI
Y
Yadav, V
G
Gail Marracci
J
Jesús Lovera
W
William R. Woodward
K
K. Bogardus
W
Whitney E. Marquardt
L
Lynne Shinto
C
Cynthia D. Morris
D
Dennis Bourdette *
DOI:10.1191/1352458505ms1143oadelete
delete原文链接
delete原文求助
delete分享
delete收藏
摘要

摘要

En 中文
Lipoic acid (LA) is an antioxidant that suppresses and treats an animal model of multiple sclerosis (MS), experimental autoimmune encephalomyelitis. The purpose of this study was to determine the pharmacokinetics (PK), tolerability and effects on matrix metalloproteinase-9 (MMP-9) and soluble intercellular adhesion molecule-1 (sICAM-1) of oral LA in patients with MS. Thirty-seven MS subjects were randomly assigned to one of four groups: placebo, LA 600 mg twice a day, LA 1200 mg once a day and LA 1200 mg twice a day. Subjects took study capsules for 14 days. We found that subjects taking 1200 mg LA had substantially higher peak serum LA levels than those taking 600 mg and that peak levels varied considerably among subjects. We also found a significant negative correlation between peak serum LA levels and mean changes in serum MMP-9 levels (tau=-0.263, P=0.04). There was a significant dose response relationship between LA and mean change in serum sICAM-1 levels (P=0.03). We conclude that oral LA is generally well tolerated and appears capable of reducing serum MMP-9 and sICAM-1 levels. LA may prove useful in treating MS by inhibiting MMP-9 activity and interfering with T-cell migration into the CNS.
Keyword:
intercellular adhesion molecule-1
lipoic acid
matrix metalloproteinase-9
multiple sclerosis
pharmacokinetics
AI总结

AI总结

对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。

期刊

Multiple Sclerosis Journal 封面图
Multiple Sclerosis Journal
IF:
5
论文数:
5.4K
被引数:
1.4W

机构

暂无机构信息
引用论文

引用论文

Unique hue loci differ with methodology
err2010-08-25
err0
PREAI
errVicki J. Volbrecht; Janice L. Nerger; Lucinda S. Baker; Armando R. Trujillo; Katie Youngpeter
err分享
err收藏
Changes in serum levels of ICAM and TNF-R correlate with disease activity in multiple sclerosis
err1999-09-01
err47
PREAI
errKhoury, SJ; Orav, EJ; Guttmann, CRG; Kikinis, R; Jolesz, FA; Weiner, HL
err分享
err收藏
Implementation of Combinatorial Genetic and Microenvironmental Engineering to Microbial-Based Field-Deployable Microbead Biosensors for Highly Sensitive and Remote Chemical Detection
err2019-09-12
err0
PREAI
errKangseok Lee; Sunho Choi; Chuntae Kim; Woo Seok Kang; Wonhak Son; Sung Chul Bae; Jin-Woo Oh; Sung Kuk Lee; Chaenyung Cha
err分享
err收藏
Changes of serum sICAM-1 and MMP-9 induced by rIFNβ-1b treatment in relapsing-remitting MS
err1999-10-22
err119
PREAI
errTrojano, M; Avolio, C; Liuzzi, GM; Ruggieri, M; Defazio, G; Liguori, M; Santacroce, MP; Paolicelli, D; Giuliani, F; Riccio, P; Livrea, P
err分享
err收藏
学者 查看更多内容